Elkan Blout Professor of Environmental Genetics, Harvard T. H. Chan School of Public Health
Harvard Medical School
David Christiani, MD, MPH, MS, is a Professor of Medicine at Harvard Medical School, Physician in Pulmonary and Critical Care Unit of Massachusetts General Hospital (MGH), and the Elkan Blout of Environmental Genetics Professor at Harvard T.H. Chan School of Public Health. He earned his MD in 1976 from Tufts University, and an MS and MPH from Harvard T.H. Chan School of Public Health. He did his post-graduate medical training at Boston City Hospital and MGH in Boston.
Dr. Christiani’s major research interest lies in the interaction between human genes and the environment. Using molecular epidemiology, he studies the impact of humans’ exposure to environmental agents on health, as well as how genetic and acquired susceptibility to these diseases can lead to cancer, acute and chronic pulmonary and cardiovascular diseases.
Working with his research collaborators, Dr. Christiani has developed biologic markers for examining pollutant-induced diseases such as lung cancer, bladder cancer, skin cancer, and upper-respiratory-tract inflammation. He has been leading a large molecular and genetic analysis of lung cancer, examining genetic factors that make people susceptible to lung cancer and predicting the outcome of treatment. Active in global collaborations since 1981, Dr. Christiani has conducted research on environmental conditions of the lung, including acute lung injury, lung cancer, and respiratory responses to environmental toxicants in Asia, Africa and Latin American. He has authored/co-authored over 700 peer-reviewed publications.
Dr. Christiani has served as an Associate Editor for the Journals Cancer Research and Carcinogenesis, and a contributing editor to Environmental Health Perspectives, the American Journal of Industrial Medicine, and Cancer Medicine. He has served on the National Environmental Health Sciences Council, and in 2012, President Obama appointed him to a 6-year term on the National Cancer Advisory Board.
Thursday, November 15
3:00 PM – 4:15 PM